Difficulty: Medium
Average Score: 86%
Practice
A female client who started chemotherapy three days ago for cancer of the breast calls the clinic reporting that she is so upset she cannot sleep. The client has several PRN medications available. Which drug should the nurse instruct her to take?
Correct answer
D
Rationale
In this scenario, the nurse should instruct the female client undergoing chemotherapy to take option D, which is Acetaminophen and diphenhydramine 2 capsules at bedtime. This combination medication is commonly used for managing insomnia, which is the client's primary concern. Acetaminophen helps with mild pain relief, and diphenhydramine is an antihistamine that induces drowsiness, aiding in sleep initiation.
Option A (Ondansetron) is an antiemetic used to control nausea and vomiting, not for sleep. Option B (Lorazepam) is a benzodiazepine used for anxiety and insomnia but may not be the best choice due to potential interactions with chemotherapy drugs. Option C (Oxycodone, acetylsalicylic acid) is for pain management, not sleep.
Educationally, this question highlights the importance of considering the holistic needs of patients undergoing chemotherapy and the appropriate selection of medications to address specific symptoms while considering potential drug interactions and side effects. It underscores the importance of thorough assessment and individualized care in pharmacological interventions.
Option A (Ondansetron) is an antiemetic used to control nausea and vomiting, not for sleep. Option B (Lorazepam) is a benzodiazepine used for anxiety and insomnia but may not be the best choice due to potential interactions with chemotherapy drugs. Option C (Oxycodone, acetylsalicylic acid) is for pain management, not sleep.
Educationally, this question highlights the importance of considering the holistic needs of patients undergoing chemotherapy and the appropriate selection of medications to address specific symptoms while considering potential drug interactions and side effects. It underscores the importance of thorough assessment and individualized care in pharmacological interventions.